The Liver Leaders Council
The Liver Leaders Council (LLC) is a corporate partnership program launched by the AASLD Foundation in 2023 which will engage industry partners annually through a portfolio of benefits, services, and strategic stakeholder conversations offered by both AASLD and the AASLD Foundation.
In addition to a portfolio of discounts, event participation opportunities and branding, the Liver Leaders Council will meet twice per year (spring- in conjunction with Digestive Diseases Week® and fall- at The Liver Meeting®) for an exclusive Liver Leaders Council Summit. These meetings will be focused on emerging issues across the spectrum of Liver Disease, bringing together industry, member-leader experts, regulators, and patients/patient advocacy groups to engage in strategic conversations around shared opportunities and challenges.
To provide a meaningful partnership between American Association for the Study of Liver Diseases Foundation and industry to collaborate and innovate through a shared commitment to invest in the future of hepatology.
We would like to recognize our Founding Members:
Boehringer-Ingelheim, CymaBay Therapeutics, Gilead, GSK, Ipsen, Intercept Pharmaceuticals, Madrigal Pharmaceuticals, Mallinckrodt, Merck, NovoNordisk, Takeda, and Salix
If you’d like to learn more about becoming a Founding Member of the Liver Leaders Council, please provide your contact information using the form here.
Membership term: January – December, renewals begin in October for the following year